Cargando…

Glu89Gln transthyretin-related amyloidosis in Italy and Bulgaria: does geographic area influence phenotype beyond the shared mutation?

Detalles Bibliográficos
Autores principales:	Gagliardi, Christian, Gospodinova, Mariana, Longhi, Simone, Milandri, Agnese, Cinelli, Mario, Tournev, Ivailo, Salvi, Fabrizio, Rapezzi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641993/ http://dx.doi.org/10.1186/1750-1172-10-S1-P23

Ejemplares similares

Cardiac involvement and clinical follow up of patients with hereditary transthyretin related amyloidosis associated with Glu89Gln mutation
por: Gospodinova, Mariana, et al.
Publicado: (2015)

Screening for hereditary transthyretin amyloidosis in Bulgaria
por: Nakov, Radislav, et al.
Publicado: (2021)

Cardiomyopathy and peripheral polyneuropathy severity in patients with Glu89Gln mutation at the time of diagnosis
por: Gospodinova, Mariana, et al.
Publicado: (2015)

Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS
por: Gentile, Luca, et al.
Publicado: (2021)

Prevalence, risk factors and correlation with cardiac involvement of carpal tunnel syndrome in amyloidosis
por: Milandri, Agnese, et al.
Publicado: (2015)

Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria
por: Chamova, Teodora, et al.
Publicado: (2022)

Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020)

A new therapy for transthyretin amyloidosis, no longer an orphan condition
por: Quarta, Candida Cristina, et al.
Publicado: (2020)

Coexistence of degenerative aortic stenosis and wild type transthyretin-related cardiac amyloidosis: a potentially dangerous association that can be non-invasively identified
por: Longhi, Simone, et al.
Publicado: (2015)

Is 99mTc-diphosphonate uptake the earliest sign of cardiac amyloidosis development in asymptomatic Glu89Gln transthyretin gene mutation carriers?
por: Minutoli, Fabio, et al.
Publicado: (2015)

Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
por: Jercan, Andreea, et al.
Publicado: (2020)

Case Report: Transthyretin Glu54Leu—a rare mutation with predominant cardiac phenotype
por: Gospodinova, Mariana, et al.
Publicado: (2023)

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
por: Sarafov, Stayko, et al.
Publicado: (2015)

Genotypic and phenotypic presentation of Glu89Gln mutation in Turkey
por: Durmus, Hacer, et al.
Publicado: (2015)

What to do when the neuropathy worsens after successful heart and liver transplantation in a Glu89Lys Transthyretin Amyloidosis?
por: Kuntzer, Thierry, et al.
Publicado: (2015)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013)

Description of the first two cases of Pompe disease in Bulgaria
por: Tournev, I, et al.
Publicado: (2013)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications
por: Fabbri, Gioele, et al.
Publicado: (2021)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis
por: Salvalaggio, Alessandro, et al.
Publicado: (2021)

Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2022)

Gln-tRNA(Gln) synthesis in a dynamic transamidosome from Helicobacter pylori, where GluRS2 hydrolyzes excess Glu-tRNA(Gln)
por: Huot, Jonathan L., et al.
Publicado: (2011)

Different phenotypes of transthyretin-associated familial amyloid polyneuropathy due to a mutation in p.Glu109Gln in members of the same family
por: Erdogan, Cagdas, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Gentile, Luca, et al.
Publicado: (2023)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy
por: Adams, David, et al.
Publicado: (2016)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
por: Matteo, Serenelli, et al.
Publicado: (2023)

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis
por: Bandera, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ka2e15onlip4duo5hohac938pn